Abilify Maintena Interactions
There are 713 drugs known to interact with Abilify Maintena (aripiprazole), along with 17 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 62 are major, 649 are moderate, and 2 are minor.
- View all 713 medications that may interact with Abilify Maintena
- View Abilify Maintena alcohol/food interactions (4)
- View Abilify Maintena disease interactions (17)
Most frequently checked interactions
View interaction reports for Abilify Maintena (aripiprazole) and the medicines listed below.
- Ativan (lorazepam)
- Ativan (lorazepam)
- benztropine
- benztropine
- buspirone
- buspirone
- clonazepam
- clonazepam
- Cymbalta (duloxetine)
- Cymbalta (duloxetine)
- gabapentin
- gabapentin
- hydroxyzine
- hydroxyzine
- Invega Sustenna (paliperidone)
- Invega Sustenna (paliperidone)
- levothyroxine
- levothyroxine
- lisinopril
- lisinopril
- olanzapine
- olanzapine
- propranolol
- propranolol
- Seroquel (quetiapine)
- Seroquel (quetiapine)
- trazodone
- trazodone
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
Abilify Maintena alcohol/food interactions
There are 4 alcohol/food interactions with Abilify Maintena (aripiprazole).
Abilify Maintena disease interactions
There are 17 disease interactions with Abilify Maintena (aripiprazole) which include:
- suicidality
- dementia
- acute alcohol intoxication
- CNS depression
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- weight gain
- anticholinergic effects
- hyperprolactinemia
- liver disease
- parkinsonism
- tardive dyskinesia
More about Abilify Maintena (aripiprazole)
- Abilify Maintena consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (63)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.